Shopping Cart

Schwabe News 2016 June- research news- Single-blind study


Single-blind study to assess the effect of Homoeopathic treatment of cancer patients against placebo

This study was aimed to assess the effect of individualised homoeopathic treatment (IHT), on clinical and quality of life (QoL), against placebo in patients suffering advanced cancer and receiving conventional palliative care. The study was conducted in Italy. For the study 16 advanced cancer patients were admitted in emergency medicine unit. Patients were divided into two groups, matched for age and clinical conditions. With the informed consent IHT and placebo treatment for study began. EORTC-QLQ-C30 (European Organization for Research and Treatment of Cancer – quality of life questionnaire containing 30 core items) questionnaire in basal conditions is used to assess patient’s mental, physical and QoL. After 1 month and 4 months of treatment statistical analysis was performed using the Student’s t-test. Result showed significant clinical improvements compared to the control. In laboratory test group of IHT had significant improvements. Important clinical problems such as anxiety, depression, anorexia, phobias, panic attacks, erectile dysfunction, frigidity, important physical disabilities, intolerable pains that did not respond to analgesics; whereas IHT group has marked improvement. The EORTC-QLQ-C30 questionnaires analysis shows that all patients had a bad perception of their QoL at baseline and encountered many difficulties in daily activities. No significant side effects were detected and also reduction in psychotropic drugs in IHT group was noticed. It was concluded by the researchers that the IHT improves the clinical condition and QoL of patients with advanced cancer. The improvement obtained is statistically significant compared to placebo.

Reference: Francesca Talarico, Costanza Maria Pullano, Sebastiano Di Salvo and Vincenzo Falabella, Single-blind study assessing the individualized homeopathic treatment of cancer patients versus placebo. Volume 105, Issue 1, Page 23, Feb’2016. Source:

Share this news